CS
NTR icon

Candriam SCA’s Nutrien NTR Stock Holding History

Candriam SCA’s Portfolio NTR Stock Details NTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,156
Closed -$405K – 710
2025
Q1 		$405K Sell
8,156
-490
-6% -$25.1K ﹤0.01% 643
2024
Q4 		$387K Sell
8,646
-571
-6% -$27.1K ﹤0.01% 639
2024
Q3 		$443K Buy
9,217
+1,611
+21% +$77.7K ﹤0.01% 639
2024
Q2 		$387K Hold
7,606
– – ﹤0.01% 645
2024
Q1 		$414K Sell
7,606
-2,074
-21% -$108K ﹤0.01% 666
2023
Q4 		$548K Sell
9,680
-700
-7% -$39.6K ﹤0.01% 652
2023
Q3 		$644K Sell
10,380
-4,321
-29% -$273K ﹤0.01% 605
2023
Q2 		$869K Hold
14,701
– – 0.01% 625
2023
Q1 		$998K Sell
14,701
-48
-0.3% -$3.7K 0.01% 699
2022
Q4 		$1.08M Sell
14,749
-91
-0.6% -$7.19K 0.01% 686
2022
Q3 		$9.93M Buy
14,840
+918
+7% +$79K 0.07% 274
2022
Q2 		$1.11M Buy
13,922
+2,247
+19% +$218K 0.01% 610
2022
Q1 		$1.21M Buy
11,675
+629
+6% +$52.1K 0.01% 622
2021
Q4 		$831K Sell
11,046
-3,143
-22% -$220K 0.01% 693
2021
Q3 		$921K Buy
14,189
+354
+3% +$21.6K 0.01% 718
2021
Q2 		$839K Sell
13,835
-535
-4% -$31.7K 0.01% 742
2021
Q1 		$663K Hold
14,370
– – 0.01% 690
2020
Q4 		$691K Sell
14,370
-4,119
-22% -$182K 0.01% 702
2020
Q3 		$723K Sell
18,489
-380
-2% -$13.8K 0.01% 663
2020
Q2 		$604K Buy
18,869
+4,717
+33% +$164K 0.01% 688
2020
Q1 		$663K Hold
14,152
– – 0.01% 690
2019
Q4 		$678K Sell
14,152
-184,004
-93% -$8.89M 0.01% 707
2019
Q3 		$9.88M Buy
198,156
+161,671
+443% +$8.25M 0.13% 187
2019
Q2 		$1.95M Sell
36,485
-137,862
-79% -$7.2M 0.02% 526
2019
Q1 		$9.2M Sell
174,347
-73,148
-30% -$3.81M 0.12% 205
2018
Q4 		$11.6M Buy
247,495
+78,243
+46% +$4.08M 0.18% 130
2018
Q3 		$9.77M Buy
169,252
+126,975
+300% +$7.03M 0.13% 196
2018
Q2 		$2.3M Buy
42,277
+27,811
+192% +$1.38M 0.04% 461
2018
Q1 		$683K Buy
+14,466
New +$725K 0.01% 641

Other funds holding NTR

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
SII
Silchester International Investors London, United Kingdom $62M AUM 14.06% 1-Year Est. Return

Candriam SCA's NTR Position: Q2 2025 in Review

Candriam SCA sold out of Nutrien (NTR) in Q2 2025, closing a stake of 8,156 shares — an estimated $405K sold.

Candriam SCA first reported a position in NTR in Q1 2018 and held it in 29 quarters. The position peaked at $11.6M in Q4 2018. 649 funds tracked by Wall St. Rank hold NTR as of Q2 2025.

  • Candriam SCA reported no remaining Nutrien position as of Q2 2025 after selling out during the quarter.
  • Candriam SCA sold 8,156 Nutrien shares in Q2 2025, an estimated $405K.
  • Candriam SCA first reported a position in Nutrien in Q1 2018 and held it in 29 quarters.
  • Candriam SCA's Nutrien position peaked at $11.6M in Q4 2018.
  • 649 funds tracked by Wall St. Rank held Nutrien as of Q2 2025.

Based on Candriam SCA's 13F filing for Q2 2025, filed 8 Aug 2025.